1. Home
  2. PEGA vs BIO Comparison

PEGA vs BIO Comparison

Compare PEGA & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEGA
  • BIO
  • Stock Information
  • Founded
  • PEGA 1983
  • BIO 1952
  • Country
  • PEGA United States
  • BIO United States
  • Employees
  • PEGA N/A
  • BIO N/A
  • Industry
  • PEGA EDP Services
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PEGA Technology
  • BIO Industrials
  • Exchange
  • PEGA Nasdaq
  • BIO Nasdaq
  • Market Cap
  • PEGA 9.2B
  • BIO 7.7B
  • IPO Year
  • PEGA 1996
  • BIO N/A
  • Fundamental
  • Price
  • PEGA $58.07
  • BIO $280.09
  • Analyst Decision
  • PEGA Buy
  • BIO Strong Buy
  • Analyst Count
  • PEGA 11
  • BIO 4
  • Target Price
  • PEGA $60.45
  • BIO $333.50
  • AVG Volume (30 Days)
  • PEGA 1.1M
  • BIO 220.7K
  • Earning Date
  • PEGA 10-22-2025
  • BIO 10-29-2025
  • Dividend Yield
  • PEGA 0.10%
  • BIO N/A
  • EPS Growth
  • PEGA 61.54
  • BIO N/A
  • EPS
  • PEGA 1.18
  • BIO 11.49
  • Revenue
  • PEGA $1,676,025,000.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • PEGA $16.35
  • BIO $2.12
  • Revenue Next Year
  • PEGA $6.37
  • BIO $2.90
  • P/E Ratio
  • PEGA $49.36
  • BIO $24.46
  • Revenue Growth
  • PEGA 12.47
  • BIO N/A
  • 52 Week Low
  • PEGA $29.84
  • BIO $211.43
  • 52 Week High
  • PEGA $60.96
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • PEGA 64.08
  • BIO 48.12
  • Support Level
  • PEGA $55.84
  • BIO $276.52
  • Resistance Level
  • PEGA $57.93
  • BIO $298.00
  • Average True Range (ATR)
  • PEGA 1.35
  • BIO 7.65
  • MACD
  • PEGA 0.55
  • BIO -2.84
  • Stochastic Oscillator
  • PEGA 88.31
  • BIO 14.28

About PEGA Pegasystems Inc.

Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: